Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires Live2025-07-11

Health care stocks advanced late Thursday afternoon, with the NYSE Health Care Index rising 0.9% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.7%.

The iShares Biotechnology ETF (IBB) increased 0.9%.

In corporate news, Ligand Pharmaceuticals (LGND) said its partner Pelthos Therapeutics (PTHS) has commercially launched Zelsuvmi, an at-home treatment for a skin infection called molluscum contagiosum. Ligand shares rose 2.1%, and Pelthos surged 73%.

Moderna (MRNA) shares popped 4.6% after it received approval from the US Food and Drug Administration for its supplemental biologics license application for its COVID-19 vaccine Spikevax in children aged six months to 11 years who have a high risk of COVID-19 disease.

GSK (GSK) climbed 1.6%. The firm said it has started shipping doses of its trivalent seasonal influenza vaccines to US health care providers and pharmacies ahead of the 2025-26 flu season.

Ultragenyx Pharmaceutical (RARE) shares fell 24% after a phase 3 study update showed that UX143 missed a key efficacy metric in pediatric and young adult patients with osteogenesis imperfecta, a rare genetic bone disorder.

Healthcare Services (HCSG) stock dropped 5.5% after the company said it expects to record non-cash charges tied to Genesis HealthCare's Chapter 11 bankruptcy filing.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2550753466?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-11 03:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2550753466","market":"nz","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Rise Late Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks advanced late Thursday afternoon, with the <a href=\"https://laohu8.com/S/NYSE\">NYSE</a> Health Care Index rising 0.9% and the <a href=\"https://laohu8.com/S/XLV\">Health Care Select Sector SPDR Fund</a> (XLV) gaining 0.7%.</p><p>The <a href=\"https://laohu8.com/S/IBB\">iShares Biotechnology ETF</a> (IBB) increased 0.9%.</p><p>In corporate news, <a href=\"https://laohu8.com/S/LGND\">Ligand Pharmaceuticals</a> (LGND) said its partner Pelthos <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (PTHS) has commercially launched Zelsuvmi, an at-home treatment for a skin infection called molluscum contagiosum. Ligand shares rose 2.1%, and Pelthos surged 73%.</p><p><a href=\"https://laohu8.com/S/MRNA\">Moderna</a> (MRNA) shares popped 4.6% after it received approval from the US Food and Drug Administration for its supplemental biologics license application for its COVID-19 vaccine Spikevax in children aged six months to 11 years who have a high risk of COVID-19 disease.</p><p>GSK (GSK) climbed 1.6%. The firm said it has started shipping doses of its trivalent seasonal influenza vaccines to US health care providers and pharmacies ahead of the 2025-26 flu season.</p><p><a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) shares fell 24% after a phase 3 study update showed that UX143 missed a key efficacy metric in pediatric and young adult patients with osteogenesis imperfecta, a rare genetic bone disorder.</p><p><a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> Services (HCSG) stock dropped 5.5% after the company said it expects to record non-cash charges tied to Genesis HealthCare's Chapter 11 bankruptcy filing.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Rise Late Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Rise Late Afternoon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-11 03:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks advanced late Thursday afternoon, with the <a href=\"https://laohu8.com/S/NYSE\">NYSE</a> Health Care Index rising 0.9% and the <a href=\"https://laohu8.com/S/XLV\">Health Care Select Sector SPDR Fund</a> (XLV) gaining 0.7%.</p><p>The <a href=\"https://laohu8.com/S/IBB\">iShares Biotechnology ETF</a> (IBB) increased 0.9%.</p><p>In corporate news, <a href=\"https://laohu8.com/S/LGND\">Ligand Pharmaceuticals</a> (LGND) said its partner Pelthos <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (PTHS) has commercially launched Zelsuvmi, an at-home treatment for a skin infection called molluscum contagiosum. Ligand shares rose 2.1%, and Pelthos surged 73%.</p><p><a href=\"https://laohu8.com/S/MRNA\">Moderna</a> (MRNA) shares popped 4.6% after it received approval from the US Food and Drug Administration for its supplemental biologics license application for its COVID-19 vaccine Spikevax in children aged six months to 11 years who have a high risk of COVID-19 disease.</p><p>GSK (GSK) climbed 1.6%. The firm said it has started shipping doses of its trivalent seasonal influenza vaccines to US health care providers and pharmacies ahead of the 2025-26 flu season.</p><p><a href=\"https://laohu8.com/S/RARE\">Ultragenyx Pharmaceutical</a> (RARE) shares fell 24% after a phase 3 study update showed that UX143 missed a key efficacy metric in pediatric and young adult patients with osteogenesis imperfecta, a rare genetic bone disorder.</p><p><a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> Services (HCSG) stock dropped 5.5% after the company said it expects to record non-cash charges tied to Genesis HealthCare's Chapter 11 bankruptcy filing.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GSK","symbol_name":"葛兰素史克","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2550753466","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2550753466","pubTimestamp":1752177431,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks advanced late Thursday afternoon, with the NYSE Health Care Index rising 0.9% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.7%.The iShares Biotechnology ETF (IBB) incr","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"GSK":"葛兰素史克","LGND":"Ligand Pharmaceuticals Inc.","BK4535":"淡马锡持仓","XLV":"健康照护类股ETF-SPDR","BK4568":"美国抗疫概念","BK4588":"碎股","GSK.UK":"葛兰素史克","BK4548":"巴美列捷福持仓","LU0566484027.USD":"安本美国小盘成长股","IBB":"生物科技指数ETF-iShares Nasdaq","LU1829250122.USD":"高盛欧洲核心股票组合Acc","LU1559883803.SGD":"Aberdeen Standard SICAV I - North American Smaller Companies Fund A Acc SGD-H","BK4551":"寇图资本持仓","PTHS":"PELTHOS THERAPEUTICS INC","BK4007":"制药","BK4137":"综合支持服务","RARE":"Ultragenyx Pharmaceutical Inc","BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","BK4532":"文艺复兴科技持仓","BK4581":"高盛持仓","BK4501":"段永平概念","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4533":"AQR资本管理(全球第二大对冲基金)","HCSG":"Healthcare Svcs Group Inc"},"translate_title":"行业更新：医疗保健股午后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GSK.UK":0.6,"PTHS":0.9,"IBB":1,"HCSG":0.9,"MRNA":1,"BNTX":0.63,"RARE":0.9,"GSK":0.9,"XLV":1,"LGND":0.9},"content_text":"Health care stocks advanced late Thursday afternoon, with the NYSE Health Care Index rising 0.9% and the Health Care Select Sector SPDR Fund (XLV) gaining 0.7%.The iShares Biotechnology ETF (IBB) increased 0.9%.In corporate news, Ligand Pharmaceuticals (LGND) said its partner Pelthos Therapeutics (PTHS) has commercially launched Zelsuvmi, an at-home treatment for a skin infection called molluscum contagiosum. Ligand shares rose 2.1%, and Pelthos surged 73%.Moderna (MRNA) shares popped 4.6% after it received approval from the US Food and Drug Administration for its supplemental biologics license application for its COVID-19 vaccine Spikevax in children aged six months to 11 years who have a high risk of COVID-19 disease.GSK (GSK) climbed 1.6%. The firm said it has started shipping doses of its trivalent seasonal influenza vaccines to US health care providers and pharmacies ahead of the 2025-26 flu season.Ultragenyx Pharmaceutical (RARE) shares fell 24% after a phase 3 study update showed that UX143 missed a key efficacy metric in pediatric and young adult patients with osteogenesis imperfecta, a rare genetic bone disorder.Healthcare Services (HCSG) stock dropped 5.5% after the company said it expects to record non-cash charges tied to Genesis HealthCare's Chapter 11 bankruptcy filing.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2550753466","isCrawlerRequest":true}